Chang-Hao Cui

Title: Chang-Hao Cui: Innovator in Ginsenoside Glycosidase Research

Introduction

Chang-Hao Cui is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the area of ginsenoside glycosidases. His work focuses on the conversion of PPD-type saponins, which has important implications for health and medicine.

Latest Patents

Chang-Hao Cui holds a patent for "Rhodanobacter ginsenosidimutans KCTC22231T-derived ginsenoside glycosidase, and use thereof." This invention relates to a polypeptide that converts PPD-type saponins into highly active deglycosylated saponins. The polypeptide selectively hydrolyzes a bond at a specific position of ginsenoside, enhancing its bioavailability. The patent also includes an amino acid sequence of the polypeptide, a nucleic acid sequence encoding the protein, and methods for preparing and utilizing the ginsenoside glycosidase.

Career Highlights

Chang-Hao Cui is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His research has led to advancements in the understanding and application of ginsenoside glycosidases, contributing to the development of new therapeutic agents.

Collaborations

He has collaborated with notable colleagues, including Sung-Taik Lee and Wan-Taek Im, to further his research and innovations in the field.

Conclusion

Chang-Hao Cui's work in ginsenoside glycosidases represents a significant advancement in biotechnology, with potential applications in health and medicine. His contributions continue to influence the field and pave the way for future innovations.